BioPharmX Stock Price - BPMX

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 0.34 ▲ 0.00 (1.18%)
Company Name Stock Ticker Symbol Market Type
BioPharmX Corporation BPMX AMEX Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.00848 -2.5% 0.3311 0.357 0.325 0.357 0.339579 16:01:06
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
818 237,931 $ 0.3339112 $ 79,448 365,400 0.3003 - 4.80
Last Trade Time Type Quantity Stock Price Currency
17:15:00 60 $ 0.327 USD

BioPharmX Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 4.70M 14.19M $ -17.26M -2.19 - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
75.49k $ - 0.00% 7.00 -

more financials information »

BioPharmX News

Loading Messages....

Latest BPMX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BPMX Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week0.350.410.3250.3459444k-0.0189-5.40%
1 Month0.40.410.3039160.3456301k-0.0689-17.23%
3 Months0.440.450.30030.3609333k-0.1089-24.75%
6 Months1.70752.11250.30031.13221M-1.3764-80.61%
1 Year4.56254.80.30032.59564M-4.2314-92.74%
3 Years7.2522.750.30035.29924M-6.9189-95.43%
5 Years70.25112.50.30035.68143M-69.9189-99.53%

BioPharmX Description

BioPharmX Corp specialty pharmaceutical company engaged in utilizing its proprietary drug delivery technologies to develop and commercialize novel prescription products that address large markets in dermatology. Its objective is to develop products that treat health or age-related conditions that are not presently being addressed or treated with drug therapies or drug delivery approaches that are sub-optimal. The company has developed its product portfolio using its proprietary drug delivery technologies, including delivery mechanisms for antibiotics, biologic materials, and molecular iodine. Its products include VI2OLET iodine dietary supplement, two clinical-stage product candidates, BPX01 and BPX03 and one development-stage product candidate, BPX02.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.